Literature DB >> 9850656

Papillary Hürthle cell carcinoma (Warthin-like tumor) of the thyroid. Report of a case with fine needle aspiration findings.

M Vasei1, P V Kumar, S A Malekhoseini, M Kadivar.   

Abstract

BACKGROUND: Papillary Hürthle cell carcinoma with lymphoplasmacytic stroma is a newly recognized variant of papillary carcinoma of the thyroid gland. Fine needle aspiration findings reveal some points that have not been reported previously. CASE: A 50-year-old female presented with a left lobe thyroid mass. Fine needle aspiration of the nodule yielded cellular smears, mostly in large and small papillary clusters of Hürthle cells, with nuclear grooves and rare nuclear inclusions in a lymphoplasmacytic background. Isolated Hürthle cell and multinucleated giant cells were also seen. Histopathologic examination of the 3-cm-diameter nodule showed papillary Hürthle cell carcinoma with lymphocytic stroma, or "Warthin-like tumor" of the thyroid, with capsular invasion.
CONCLUSION: The presence of papillary clusters with nuclear features of papillary carcinoma and oxyphilic cytoplasm in a lymphoplasmacytic background should raise the diagnosis of Warthin-like tumor of the thyroid.

Entities:  

Mesh:

Year:  1998        PMID: 9850656     DOI: 10.1159/000332181

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  3 in total

1.  Warthin tumor-like variant of papillary thyroid carcinoma: a case with dedifferentiation (anaplastic changes) and aggressive biological behavior.

Authors:  King Yin Lam; Chung Yau Lo; William I Wei
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Fine Needle Aspiration Cytology of Warthin-like Papillary Thyroid Carcinoma: A Brief Case Report.

Authors:  Yosep Chong; Sungwook Suh; Tae-Jung Kim; Eun Jung Lee
Journal:  Korean J Pathol       Date:  2014-04-28

3.  Cytomorphologic Diversity of Papillary Thyroid Carcinoma.

Authors:  Vidya Monappa; Ranjini Kudva
Journal:  J Cytol       Date:  2017 Oct-Dec       Impact factor: 1.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.